Cargando…

Optimization of Heart Failure Treatment by Heart Rate Reduction

Heart failure (HF) treatment should be optimized in addition to guideline-directed and recommended drugs to achieve an appropriate heart rate (i.e. 50−60 bpm) by ivabradine in patients with a heart rate >70 bpm in sinus rhythm and with an ejection fraction ≤35%. Heart rate reduction was to reduce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Böhm, Michael, Bewarder, Yvonne, Kindermann, Ingrid, Slawik, Jonathan, Wintrich, Jan, Werner, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Heart Failure 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536732/ https://www.ncbi.nlm.nih.gov/pubmed/36263079 http://dx.doi.org/10.36628/ijhf.2019.0009

Ejemplares similares

Timely and individualized heart failure management: need for implementation into the new guidelines
por: Abdin, Amr, et al.
Publicado: (2021)

‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor
por: Abdin, Amr, et al.
Publicado: (2021)

Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer
por: Slawik, Jonathan, et al.
Publicado: (2020)

Neues zur Diagnostik und Therapie der Herzinsuffizienz
por: Wintrich, Jan, et al.
Publicado: (2021)

Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future
por: Wintrich, Jan, et al.
Publicado: (2020)

Management strategies in heart failure with preserved ejection fraction
por: Wintrich, Jan, et al.
Publicado: (2022)

Heart-Focused Anxiety, General Anxiety, Depression and Health-Related Quality of Life in Patients with Atrial Fibrillation Undergoing Pulmonary Vein Isolation
por: Pavlicek, Valérie, et al.
Publicado: (2022)

Optimized Treatment and Heart Rate Reduction in Chronic Heart Failure
por: Moreno, Irineu Blanco, et al.
Publicado: (2013)

Physiological monitoring in the complex multimorbid heart failure patient - Conclusions
por: Böhm, Michael, et al.
Publicado: (2019)

Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR‐Preserved trial
por: Böhm, Michael, et al.
Publicado: (2022)

Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
por: Abdin, Amr, et al.
Publicado: (2022)

Benefit of Heart Rate Reduction in Heart Failure
por: Hasenfuss, Gerd
Publicado: (2010)

Impedance‐based remote monitoring in patients with heart failure and concomitant chronic kidney disease
por: Wintrich, Jan, et al.
Publicado: (2023)

Heart Rate Reduction and Outcomes in Heart Failure Outpatients
por: Memenga, Felix, et al.
Publicado: (2023)

Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice
por: McDonagh, Theresa, et al.
Publicado: (2018)

Mitral valve interventions in heart failure
por: Lavall, Daniel, et al.
Publicado: (2018)

Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada
por: Huitema, Ashlay A., et al.
Publicado: (2020)

Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study)
por: Fu, M., et al.
Publicado: (2017)

Opportunities for Care Optimization and Hospitalization Reduction for Older Persons With Heart Failure
por: Azad , Nahid
Publicado: (2019)

Transient heart rate reduction improves acute decompensated heart failure‐induced left ventricular and coronary dysfunction
por: Peschanski, Nicolas, et al.
Publicado: (2021)

Shielding the Heart: Preload Reduction Therapies in Heart Failure
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2023)

HEART FAILURE HOSPITALIZATION RATE REDUCTION DURING COVID-19 PANDEMIC
por: D’Amato, Andrea, et al.
Publicado: (2021)

Optimizing outcomes in heart failure: 2022 and beyond
por: Jankowska, Ewa A., et al.
Publicado: (2023)

The need for dedicated advanced heart failure units to optimize heart failure care: impact of optimized advanced heart failure unit care on heart transplant outcome in high‐risk patients
por: Kreusser, Michael M., et al.
Publicado: (2018)

Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
por: González-Juanatey, José Ramón, et al.
Publicado: (2023)

Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment
por: Youn, Jong-Chan, et al.
Publicado: (2023)

Changes in quality of life, depression, general anxiety, and heart‐focused anxiety after defibrillator implantation
por: Kindermann, Ingrid, et al.
Publicado: (2021)

Optimal diuretic strategies in heart failure
por: Suri, Sarabjeet S., et al.
Publicado: (2021)

High Exogenous Antioxidant, Restorative Treatment (Heart) for Prevention of the Six Stages of Heart Failure: The Heart Diet
por: Singh, Ram B., et al.
Publicado: (2022)

Optimizing Therapies in Heart Failure: The Role of Potassium Binders
por: Scicchitano, Pietro, et al.
Publicado: (2022)

Heart rate – A complex prognostic marker in acute heart failure
por: Olligs, Jan, et al.
Publicado: (2019)

Renal Denervation for Chronic Heart Failure: Background and Pathophysiological Rationale
por: Böhm, Michael, et al.
Publicado: (2017)

Caloric restriction-mimetics for the reduction of heart failure risk in aging heart: with consideration of gender-related differences
por: Pang, Lei, et al.
Publicado: (2022)

Moving the Dial on Heart Failure Patient Adherence Rates
por: Makris, Eleanna, et al.
Publicado: (2020)

Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I (f) Inhibitor Ivabradine Trial (SHIFT) Trial
por: Böhm, Michael, et al.
Publicado: (2016)

Effects of selective heart rate reduction with ivabradine on LV function and central hemodynamics in patients with chronic coronary syndrome
por: Hohneck, Anna Lena, et al.
Publicado: (2021)

Heart rate and blood pressure monitoring in heart failure
por: Ponikowski, Piotr, et al.
Publicado: (2019)

A practical approach to the guideline‐directed pharmacological treatment of heart failure with reduced ejection fraction
por: Abdin, Amr, et al.
Publicado: (2022)

Cytokines as new treatment targets in chronic heart failure
por: Damås, Jan Kristian, et al.
Publicado: (2001)

Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?
por: Guo, Yong-Fang, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gsc4acpdlr7al584u2hnms79fo